Local and Systemic Control After Ablative and Limb Sparing Surgery in Patients With Osteosarcoma
- 1 January 1999
- journal article
- research article
- Published by Wolters Kluwer Health
- Vol. 358 (358) , 120???127-127
- https://doi.org/10.1097/00003086-199901000-00015
Abstract
Limb salvage surgery in patients with osteosarcoma is reported to cause a higher rate of local recurrences with a poorer chance of survival. It was the aim of the study to analyze differences between ablative and limb sparing surgery in patients with osteosarcoma who are treated with chemotherapy with respect to local and systemic tumor control and to determine independent prognostic factors. One hundred thirty consecutive patients younger than the age of 21 years who were operated on at the authors' institution for osteosarcoma of the extremities were reviewed. Histologic evaluations of surgical margins according to Enneking and coworkers revealed mostly wide (n = 109) and radical (n = 10) resection margins. The 5-year disease free survival rate was 60% for those patients treated by amputation and 71% for those treated by limb salvage. The overall local recurrence rate was 2.3%; 4.3% for ablation but only 1.2% for limb sparing surgeries. Multivariate analysis showed an independent effect of tumor volume, response to chemotherapy, and as expected, metastases at the time of diagnosis on overall survival. These data indicate that in patients where wide or radical tumor resection can be achieved, no difference in the outcome between ablative and limb sparing surgery occurred in local and systemic tumor control.Keywords
This publication has 14 references indexed in Scilit:
- Osteosarcoma: relationship of response to preoperative chemotherapy and type of surgery to local recurrence.Journal of Clinical Oncology, 1996
- Prognostic factors in osteosarcoma: a critical review.Journal of Clinical Oncology, 1994
- The multi-institutional osteosarcoma study: An updatePublished by Springer Nature ,1993
- Survival, prognosis, and therapeutic response in osteogenic sarcoma. The memorial hospital experienceCancer, 1992
- Die Grenzen der Extremitätenerhaltung - Amputation Versus ResektionZeitschrift für Orthopädie und ihre Grenzgebiete, 1992
- Weekly high-dose methotrexate and doxorubicin for osteosarcoma: the Dana-Farber Cancer Institute/the Children's Hospital--study III.Journal of Clinical Oncology, 1987
- The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the ExtremityNew England Journal of Medicine, 1986
- Osteosarcoma: Fifteen Years LaterNew England Journal of Medicine, 1985
- Possibilities and limitations of limb-preserving therapy for bone tumors todayZeitschrift für Krebsforschung und Klinische Onkologie, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958